Literature DB >> 22842883

[HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].

R Offergeld1, S Ritter, O Hamouda.   

Abstract

The Robert Koch Institute collects and evaluates data on the prevalence and incidence of HIV, hepatitis C (HCV), hepatitis B (HBV) and syphilis infections among blood and plasma donors in Germany according to article 22 of the Transfusion Act. This report includes data from all blood donation services in Germany for 2008-2010. The prevalence for HIV ranged from 6.6-7.0/100,000, for HCV from 68.9-81.6/100,000, for HBV from 116.2-136.6/100,000 and for syphilis from 31.0-42.1/100,000 donations. The proportion of incident infections per 100,000 donations ranged from 0.8-0.9 for HIV, 0.8-1.0 for HCV, 0.3-0.5 for HBV and 1.4-1.6 for syphilis. Since 2001 the prevalence and incidence of HBV and HCV among blood has declined whereas incident HIV infections reached a peak in 2008 and 2010 and show an increasing trend. Also, the proportion of syphilis infections among first time donors was highest in 2010. Significant differences in infection prevalence and incidence were found between the sexes, different age groups and different donation types. In order to optimise donor selection a validated donor questionnaire should be used and confidentiality in all steps of donation should be assured. The possibility of a confidential self-exclusion should be explicitly pointed out to donors.

Entities:  

Mesh:

Year:  2012        PMID: 22842883     DOI: 10.1007/s00103-012-1516-1

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  14 in total

1.  Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

Authors:  Michael Chudy; Julia Kress; Jochen Halbauer; Margarethe Heiden; Markus B Funk; C Micha Nübling
Journal:  Transfus Med Hemother       Date:  2013-12-19       Impact factor: 3.747

2.  Blood donation by elderly repeat blood donors.

Authors:  Thomas Zeiler; Jutta Lander-Kox; Timo Alt
Journal:  Transfus Med Hemother       Date:  2014-07-04       Impact factor: 3.747

3.  Implementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres.

Authors:  Silke De Zolt; Rolf Thermann; Thorsten Bangsow; Lutz Pichl; Benjamin Müller; Christine Jork; Marijke Weber-Schehl; Doris Hedges; Ingo Schupp; Patrick Unverzagt; Katrin de Rue; W Kurt Roth
Journal:  Transfus Med Hemother       Date:  2016-05-11       Impact factor: 3.747

4.  Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy.

Authors:  Mohamed A Daw; Amira Shabash; Abdallah El-Bouzedi; Aghnya A Dau; Moktar Habas
Journal:  World J Virol       Date:  2016-02-12

5.  Good Feasibility of the New German Blood Donor Questionnaire.

Authors:  Claudia Houareau; Robert Deitenbeck; Ariane Sümnig; Anette Moeller; Christiane Saadé; Frank Stötzer; Margarethe Heiden; Hinnak Northoff; Ruth Offergeld
Journal:  Transfus Med Hemother       Date:  2017-07-14       Impact factor: 3.747

Review 6.  Selecting the Right Donors - Still a Challenge: Development of a Uniform Donor Questionnaire in Germany.

Authors:  Ruth Offergeld; Margarethe Heiden
Journal:  Transfus Med Hemother       Date:  2017-07-18       Impact factor: 3.747

7.  Algorithms for the Testing of Tissue Donors for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus.

Authors:  Axel Pruß; Akila Chandrasekar; Jacinto Sánchez-Ibáñez; Sophie Lucas-Samuel; Ulrich Kalus; Holger F Rabenau
Journal:  Transfus Med Hemother       Date:  2020-12-22       Impact factor: 3.747

8.  Seroprevalence and risk factors on Syphilis among blood donors in Chengdu, China,from 2005 to 2017.

Authors:  Shuangli Liu; Liping Luo; Guangxiang Xi; Like Wan; Li Zhong; Xue Chen; Tianxiang Gong; Shuping Li; Yi He; Na Li
Journal:  BMC Infect Dis       Date:  2019-06-10       Impact factor: 3.090

9.  Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.

Authors:  Ida Sperle; Gyde Steffen; Siv Aina Leendertz; Navina Sarma; Sandra Beermann; Roma Thamm; Yanita Simeonova; Markus Cornberg; Heiner Wedemeyer; Viviane Bremer; Ruth Zimmermann; Sandra Dudareva
Journal:  Front Public Health       Date:  2020-08-28

10.  The epidemiology of Hepatitis B, C and D in Germany: A scoping review.

Authors:  Gyde Steffen; Ida Sperle; Siv Aina Leendertz; Navina Sarma; Sandra Beermann; Roma Thamm; Viviane Bremer; Ruth Zimmermann; Sandra Dudareva
Journal:  PLoS One       Date:  2020-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.